A first-in-human phase I study of JNJ-26481585, an oral hydroxamate hi
- This topic has 0 replies, 1 voice, and was last updated 12 years, 8 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
A first-in-human phase I study of JNJ-26481585, an oral hydroxamate histone deacetylase inhibitor (HDACi), in patients with advanced solid tumours.
http://www.ncri.org.uk/ncriconference/2011abstracts/abstracts/B62.html
Viewing 1 post (of 1 total)
- The forum ‘New Developments’ is closed to new topics and replies.